Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

Authors: Bernard Zinman, Christoph Wanner, John M. Lachin, David Fitchett, Erich Bluhmki et al.

Year: 2015

EmpagliflozinMedicineHazard ratioMyocardial infarctionInternal medicine